©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 110890
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110890
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110890
Figure 6 Lack of cytoplasmic programmed cell death protein 1 ligand 1 expression in tumor cells.
A: Lack of cytoplasmic programmed cell death protein 1 ligand 1 (cPDCD1 LG1) expression at the invasive edge of the tumor [in < 20% of tumor cells (TCs)]; B: Lack of cPDCD1 LG1 expression in the central part of the tumor (in ≥ 20% of the TCs); C: Lack of cPDCD1 LG1 expression in most of the tumor parenchyma; D: Severe basophilia and elongated shape of the TC nuclei in the absence of cPDCD1 LG1 expression. Staining with anti-PDCD1 LG1 antibodies, A-C: Scale bar is 200 μm, D: Scale bar is 50 μm.
- Citation: Senchukova MA, Zubareva EY, Saidler NV, Krivolapova LV. Lack of cytoplasmic expression of a new marker programmed cell death ligand-1 in tumor cells is significant. World J Exp Med 2025; 15(4): 110890
- URL: https://www.wjgnet.com/2220-315x/full/v15/i4/110890.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i4.110890